Skip to main content
. 2017 Sep 30;8(56):95865–95879. doi: 10.18632/oncotarget.21430

Table 3. IC50 valuesa (μM) of compounds 1-8 against carcinoma and normal tissue cell lines.

Carcinoma cell lines Normal tissue cell lines
No. U2OS SW620 ES-2 Lo2 Vero
1 111.40±1.29 45.02±1.23 55.50±1.08 150.30±1.09 >300
2 54.24±1.10 103.80±1.07 76.78±1.09 >300 260.40±1.16
3 73.19±1.24 70.93±1.08 90.58±1.12 >300 >300
4 66.44±1.11 56.46±1.15 64.24±1.28 279.10±2.17 >300
5 64.40±1.08 61.80±±1.06 80.13±3.56 >300 >300
6 57.79±1.07 53.72±1.06 37.26±3.56 >300 >300
7 96.30±1.13 100.70±1.07 74.45±1.17 >300 >300
8 95.36±1.05 55.21±1.16 60.88±1.34 >300 >300
(S)-Cb 32.28±1.28 17.50±1.11 9.09±1.06 26.01±1.20 16.69±1.15

a IC50 values of the isolated compounds were obtained from the mean OD values of the triplicate tests versus the drug concentration curves.

b (S)-C represents (S)-crizotinib, which was used as positive control.